Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Fastenal Releases 2024 Environmental, Social, and Governance (ESG) Report
-
Surf Air Mobility Reports Financial Results for Fourth Quarter and Full Year Ended December 31, 2023
-
Ascent Industries Reports Fourth Quarter and Full Year 2023 Results
-
Amneal to Ring the Nasdaq Closing Bell on April 2, 2024
-
Sypher Secures Strategic Partnership with FAIA to Fuel Growth
-
Medpace Holdings, Inc. to Report First Quarter 2024 Financial Results on April 22, 2024
-
Bristol Myers Squibb Announces Pivotal KRYSTAL-12 Confirmatory Trial Evaluating KRAZATI (adagrasib) Meets Primary Endpoint of Progression-Free Survival for Patients with Pretreated KRASG12C-Mutated Lo
-
Cartesian Therapeutics Announces Approval of Conversion of Series A Convertible Preferred Stock and Plans to Effect Reverse Stock Split
-
Werner Enterprises to Announce First Quarter Earnings and Host Earnings Call on April 30, 2024
-
Huntington Bancshares Incorporated Declares Cash Dividend On Its Series I Preferred Stock
-
Rexford Industrial Acquires Blackstone Industrial Assets in Combined $1 Billion Investment
-
Domo Introduces Groundbreaking AI Features to Expand Domo.AI Framework and Bring the Transformative Power of AI to All
-
ENDRA Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
-
Arcadia Biosciences (RKDA) Announces Fourth-Quarter and Full-Year 2023 Financial Results and Business Highlights
-
Myomo Appoints Heather Getz to its Board of Directors
-
Accelerate Diagnostics Reports Fourth Quarter and Full-Year 2023 Financial Results
-
Yelp Appoints Dan Jedda to its Board of Directors as George Hu Steps Down
-
Energous Corporation Reports 2023 Results
-
National Storage Affiliates Trust Announces Promotion of Melissa Cameron to Chief Marketing Officer
-
Emeren Announces Fourth Quarter and Full Year 2023 Financial Results
-
Heron Therapeutics Announces Presentation at the 23rd Annual Needham Virtual Healthcare Conference
-
TFF Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results
-
Vermilion Energy Inc. Confirms First Quarter 2024 Release Date and Filing of the Management Information Circular in Connection with the Annual General Meeting of Shareholders
-
BGC Group Updates its Outlook for the First Quarter of 2024
-
Dorchester Minerals, L.P. Announces Acquisition of Mineral Interests
-
Sharecare announces fourth quarter and full year 2023 financial results and operational highlights
-
ICF Announces Timing of First Quarter 2024 Earnings Release and Conference Call
-
Absci to Participate in the 23rd Annual Needham Virtual Healthcare Conference
-
ACELYRIN, INC. Reports Full Year 2023 Financial Results and Recent Highlights
-
Precigen and Recurrent Respiratory Papillomatosis Foundation to Hold Inaugural International RRP Awareness Day on June 11th
-
Fulcrum Therapeutics to Participate at the Cantor Virtual Muscular Dystrophy Symposium
-
Olin Corporation First Quarter 2024 Earnings Conference Call Announcement
-
Planet to Provide Carbon Mapper, Inc. with Hyperspectral Data Until 2030
-
Paragon 28 Adds to Suite of Novel Syndesmosis Repair Solutions with Launch of Grappler® R3INFORCE™ Extraosseous Repair System
-
Dime Community Bancshares Declares Quarterly Cash Dividend for Common Stock
-
Global-e Announces Filing of Form 20-F for the Fiscal Year Ended December 31, 2023
-
Utz Brands, Inc. Increases Quarterly Cash Dividend
-
Femasys Announces Financial Results for Year Ended December 31, 2023 and Provides Corporate Update
-
Candel Therapeutics Announces Oral Presentation During the 5th Glioblastoma Drug Development Summit with Update on Phase 1b Clinical Trial of CAN-3110 in Recurrent High-Grade Glioma
-
Vivos Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Operational Update
-
CGRA Announces Completion and Publication of 2023 Annual Disclosure
-
Acuity Brands Declares Quarterly Dividend
-
Ardelyx, Inc. Reports Employment Inducement Grants
-
Leading Proxy Advisory Firms Recommend ContextLogic Stockholders Vote “FOR” Pending Transaction with Qoo10
-
Telesis Bio Reports Fourth Quarter and Full Year 2023 Financial Results
-
Helius Medical Technologies, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results
-
Sixth Street Specialty Lending, Inc. Schedules Earnings Release and Conference Call to Discuss its First Quarter Ended March 31, 2024 Financial Results
-
Assembly Biosciences Reports Fourth Quarter and Year End 2023 Financial Results and Recent Highlights
-
ASML cautions investors regarding Tutanota LLC’s “mini-tender” offer
-
Enliven Therapeutics to Share Initial Proof of Concept Data from Phase 1 Clinical Trial of ELVN-001 and Host Virtual Key Opinion Leader Event on April 11, 2024

